# [SCI-Idea] Synthetic Biology & Programmable Living Systems
⏎
**Synthetic biology** is the design and construction of biological systems with novel, engineered functions — treating genetic code as software, metabolic pathways as circuits, and cells as programmable factories.
⏎
## Overview
⏎
Synthetic biology combines DNA synthesis, CRISPR editing, metabolic engineering, and computational design to create organisms with capabilities not found in nature. Milestones: Venter's synthesis of the first synthetic bacterial genome (Mycoplasma mycoides JCVI-syn1.0, 2010); the Sc2.0 project (synthetic yeast chromosomes, ~16 completed by 2023); cell-free systems producing proteins outside any living cell; engineered organisms producing artemisinin (anti-malarial, Amyris/Sanofi), spider silk (Bolt Threads), and industrial enzymes.
⏎
Current frontier: **biological computers** (genetic circuits performing logic operations in living cells), **living therapeutics** (engineered bacteria that sense tumour microenvironment and release cytokines), **programmable morphogenesis** (organoids and synthetic embryo-like structures, Huch lab), and **carbon-negative biology** (organisms engineered to consume CO₂ and produce biodegradable materials).
⏎
## Key Research Groups & Companies
⏎
Ginkgo Bioworks (USD 15B valuation at IPO, 2021), Twist Bioscience (DNA synthesis), Zymergen (acquired by Ginkgo), Amyris (flavours, fragrances, fuel), Pivot Bio (nitrogen-fixing microbes for agriculture), Solugen (biochemicals), Impossible Foods (animal-free protein).
⏎
## Economic Potential
⏎
McKinsey Global Institute (2020): synthetic biology could address ~60% of physical inputs to the global economy through biological manufacturing — chemicals, materials, food, fuel, medicine. Estimated economic impact: USD 2–4 trillion/year by 2030–2040. Agriculture alone (nitrogen-fixing microbes replacing synthetic fertiliser): USD 100B+/year.
⏎
## Discovery Character
⏎
**Surprise level**: High — the speed of capability development (from reading genomes in 2003 to writing them by 2010, to editing them precisely by 2014) has consistently exceeded predictions.
⏎
**Mode**: Edisonian at the cellular-engineering level (biological complexity surprises even expert designers), increasingly systematic with AI-aided DNA design (Evozyme, ProteinMPNN, AlphaFold2 for enzyme design).
⏎
## What This Enables
⏎
- **[TECH-Idea] mRNA & RNA Therapeutics** — synthetic biology designs optimised mRNA sequences, lipid nanoparticles, and self-amplifying RNA systems for therapeutic delivery.
- **[TECH-Idea] Direct Air Carbon Capture** — engineered organisms (cyanobacteria, algae, CO₂-fixing enzymes) could provide biological carbon capture at costs far below current abiotic DAC technology.
⏎
# Parents
⏎
* [SCI] Molecular Biology & Biochemistry⏎